- ►nih.gov J Costa, M Borges, C David, AV Carneiro - British Medical Journal, 2006 - bmj.com The prevalence of diabetes mellitus is increasing. Up to 218 mil- lion people
are likely to have the disease by 2010.1 The current understanding is that type
2 diabetes mellitus is a metabolic dis- order, defined by hyperglycaemia, ... Cited by 144 - Related articles - BL Direct - All 9 versions
RA Hayward, TP Hofer, S Vijan - Annals of internal medicine, 2006 - Am Coll Physicians Recent national recommendations have proposed that physicians should titrate
lipid therapy to achieve low-density lipoprotein (LDL) cholesterol levels less
than 1.81 mmol/L (<70 mg/dL) for patients at very high cardiovascular risk ... Cited by 98 - Related articles - BL Direct - All 6 versions
A Garg - The Lancet, 2004 - Elsevier In this issue of The Lancet, Helen Colhoun and colleagues report the results of
the Collaborative Atorvastatin Diabetes Study (CARDS), and document the efficacy
and safety of low-dose atorvastatin treatment in primary prevention of ... Cited by 37 - Related articles - All 2 versions
- ►ahajournals.org V van Weel, M de Vries, PJ Voshol, RE … - Arteriosclerosis, thrombosis, and vascular biology, 2006 - Am Heart Assoc Methods and Results— Femoral artery occlusion was performed in
streptozotocin(STZ)-treated mice, nonobese diabetic (NOD) mice, and
insulin-resistant Ob/Ob mice on regular diet, and APOE3*Leiden mice on ... Cited by 25 - Related articles - All 10 versions
- ►oxfordjournals.org S Ahmed, CP Cannon, SA Murphy, E … - European heart journal, 2006 - Eur Soc Cardiology Methods and results We explored this question in data from the Pravastatin or
Atorvastatin Evaluation and Infection Therapy (PROVE IT) TIMI 22 trial, which
tested standard (pravastatin 40 mg) vs. intensive (atorvastatin 80 mg) ... Cited by 23 - Related articles - BL Direct - All 6 versions
- ►shouxi.net EH Harris - Clinical diabetes, 2005 - Am Diabetes Assoc Individuals with type 2 diabetes have a higher incidence of liver function test
abnormalities than individuals who do not have diabetes. Mild chronic elevations
of transaminases often reflect underlying insulin resistance. Elevation of ... Cited by 13 - Related articles - BL Direct - All 5 versions
- ►nih.gov PA Ohman-Strickland, AJ Orzano, SV Hudson, … - Annals of Family Medicine, 2008 - Annals Family Med RESULTS Compared with practices employing PAs, practices employing NPs were more
likely to measure hemoglobin A 1c levels (66% vs 33%), lipid levels (80% vs
58%), and urinary microalbumin levels (32% vs 6%); to have treated for high ... Cited by 14 - Related articles - BL Direct - All 11 versions
KA Sewright, PM Clarkson, PD Thompson - Current Atherosclerosis Reports, 2007 - Springer 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins) are
generally well-tolerated lipid- lowering drugs. However, they are associated
with myopathy, and incidence rates of muscle-related complaints predicted ... Cited by 10 - Related articles - BL Direct - All 2 versions
M Del Pilar Solano, RB Goldberg - Endocrinology and metabolism clinics of North America, 2005 - Elsevier Cardiovascular disease (CVD) is a major cause of morbidity and mortality among
subjects who have diabetes. It is estimated that cardiovascular complications
are responsible for up to 75% of deaths among people who have type 2 ... Cited by 10 - Related articles - All 3 versions
JK Kirk, KR Huber, CR Clinch - NC Med J, 2005 - ncmedicaljournal.com NC Med J November/December 2005, Volume 66, Number 6 ... Background:
Cardiovascular disease is the leading cause of mortality in patients with
diabetes, but goals for reduction of modifiable cardiovascular risk factors ... Cited by 10 - Related articles - View as HTML - BL Direct - All 5 versions
